drugset / Trial / NCT06723782

Surgical Release of Hand Tendons with Wrapping of the Released Tendon Using an Amniotic Membrane

NCT06723782 ↗

Phase 2 Recruiting 16 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate whether an amniotic membrane can function as an effective anti-adhesive barrier following surgical release of tendon adhesions. The main question the clinical trial aims to answer is: \- Can wrapping an amniotic membrane around a surgically released tendon help reduce recurrence of adhesions and promote recovery of hand functionality? Participants will: * Undergo surgical treatment (surgical release of the tendon adhesions and wrapping of the amniotic membrane around the release tendon) on Day 0. * Visit the center for a series of tests 15 days, 6 weeks, 3 months, 6 months after the surgical intervention.

Timeline

Start
2024-02-15
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AMTRIX-D Unknown — —

Indications

No indication recorded.